Butantan Institute Director Dimas Covas, left, and Sao Paulo state Health Secretary Dr. Jean Gorinchteyn, give a press conference about the health regulator Anvisa’s decision to halt clinical trials of the experimental coronavirus vaccine CoronaVac in Sao Paulo, Brazil, Tuesday, Nov. 10, 2020. (Andre Penner/AP)
Brazil suspends coronavirus vaccine trial after participant’s ‘serious adverse event’

Prepare Now Before its too Late
Discover where products are available & compare prices